New England Journal of Medicine · 1 Oct 2026 · Journal Article

Joint Clinical Assessments - A New Chapter in European Pharmaceutical Policy.

Naci, Wieseler

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population.
The Lancet Oncology · 1 Oct 2026 · Review
Expanding cancer susceptibility testing to the general population requires careful evaluation of clinical and public health benefits, with evidence supporting its use mainly for well-established genes.
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790443
Open in JClub
Beyond mortality: A multi-outcome assessment of health economic benefits from air pollution control in China.
Environmental research · 1 Oct 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42624321
Open in JClub
Development and validation of early warning scores predicting 24-hour mortality addressing intercurrent medical interventions: a multi-centre retrospective cohort study of 2,08 million hospital encounters
medRxiv · 1 Oct 2026 · Preprint
Read the brief in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.1101/2025.10.12.25337794
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read